• PDF: Delivered by email usually within 12 to 24 UK business hours.

China Wound Care Management Industry Report
Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

China Wound Care Management Industry Report Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment and Supplies

This report is an essential source for in-depth information and data relating to China woundcare medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care devices in China.

Scope

  • The report provides sector information broken down into detailed categories and segments in country.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Wound Care Management
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
      • 3.2.1 Healthcare Personnel Data
      • 3.2.2 Healthcare Facilities Data
    • 3.3 Healthcare Policy
  • 4 Wound Care Management in China
    • 4.1 Wound Care Management Overall Revenues (2000-2012)
    • 4.2 Wound Care Management Overall Volume (2000-2012)
    • 4.3 Wound Care Management Overall Company Shares (2005-2006)
  • 5 Wound Closure Devices in China
    • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
      • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
      • 5.1.2 Hemostats Overall Revenues (2000-2012)
      • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
    • 5.2 Wound Closure Devices Overall Volume (2000-2012)
      • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
      • 5.2.2 Hemostats Overall Volume (2000-2012)
      • 5.2.3 Tissue Sealants Overall Volume (2000-2012)
    • 5.3 Wound Closure Devices Average Price (2000-2012)
      • 5.3.1 Hemostats Average Price (2000-2012)
      • 5.3.2 Tissue Sealants Average Price (2000-2012)
      • 5.3.3 Skin Closure Devices Average Price (2000-2012)
    • 5.4 Wound Closure Devices Distribution Share (2000-2012)
    • 5.5 Wound Closure Devices Company Share (2000-2012)
  • 6 Ostomy in China
    • 6.1 Ostomy Overall Revenue (2000-2012)
    • 6.2 Ostomy Overall Volume (2000-2012)
    • 6.3 Ostomy Average Price (2000-2012)
    • 6.4 Ostomy Distribution Share (2005-2006)
    • 6.5 Ostomy Company Share (2005-2006)
  • 7 Advanced Wound Management in China
    • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
    • 7.2 Advanced Wound Management Overall Volume (2000-2012)
    • 7.3 Advanced Wound Management Average Price (2000-2012)
    • 7.4 Advanced Wound Management Distribution Share (2005-2006)
    • 7.5 Advanced Wound Management Company Share (2005-2006)
  • 8 Traditional Wound Management in China
    • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
    • 8.2 Traditional Wound Management Overall Volume (2000-2012)
    • 8.3 Traditional Wound Management Average Price (2000-2012)
    • 8.4 Traditional Wound Management Distribution Share (2000-2012)
    • 8.5 Traditional Wound Management Company Share (2000-2012)
  • 9 Compression Therapy in China
    • 9.1 Compression Therapy Category Revenue
    • 9.2 Compression Therapy Category Volume (2000-2012)
    • 9.3 Compression Therapy Average Price (2000-2012)
    • 9.4 Compression Therapy Distribution Share (2000-2012)
    • 9.5 Compression Therapy Company Share (2000-2012)
  • 10 Covidien Ltd./Tyco Healthcare Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Imaging Solutions
      • 10.2.2 Medical Devices
      • 10.2.3 Medical Supplies
      • 10.2.4 Pharmaceutical Products
      • 10.2.5 Retail Products
      • 10.2.6 Products
      • 10.2.7 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 Covidien Ltd./Tyco Healthcare Strengths
      • 10.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
      • 10.4.3 Covidien Ltd./Tyco Healthcare Opportunities
      • 10.4.4 Covidien Ltd./Tyco Healthcare Threats
    • 10.5 Financial and Operational Review
      • 10.5.1 Financial Statements
      • 10.5.2 Financial Ratios
    • 10.6 Locations And Subsidiaries
    • 10.7 Financial Deals Landscape
      • 10.7.1 Covidien Signs An Agreement With Allergan
      • 10.7.2 Covidien Acquires Scandius Biomedical
      • 10.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
      • 10.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
      • 10.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
      • 10.7.6 Covidien To Sell European Incontinence Business
      • 10.7.7 Covidien To Acquire Tissue Science Laboratories
    • 10.8 Recent Developments
      • 10.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
      • 10.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
      • 10.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
      • 10.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
      • 10.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
      • 10.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
      • 10.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
      • 10.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
      • 10.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
      • 10.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
    • 10.9 Covidien Ltd./Tyco Healthcare Pipeline Products
      • 10.9.1 PleuraSeal Lung Sealant System
      • 10.9.2 Sandman Intro CPAP Device
  • 11 3M Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Consumer and Office
      • 11.2.2 Display and Graphics
      • 11.2.3 Electro and Communications
      • 11.2.4 Health Care
      • 11.2.5 Industrial and Transportation
      • 11.2.6 Safety, Security and Protection Services
      • 11.2.7 Products
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 3M Company Strengths
  • 3M Company Weaknesses
  • 3M Company Opportunities
  • 3M Company Threats
    • 11.5 Financial and Operational Review
    • 11.6 Locations And Subsidiaries
    • 11.7 Financial Deals Landscape
      • 11.7.1 3M Canada Acquires Les Entreprises Solumed
      • 11.7.2 3M Acquires Bondo
      • 11.7.3 3M Acquires Lingualcare
      • 11.7.4 3M Acquires Abzil Industria E Comercio
      • 11.7.5 3M Acquires Neo Plast
      • 11.7.6 3M Acquires Assets Of DMS Chile
      • 11.7.7 3M Acquires Business Of Innovative Paper Technologies
      • 11.7.8 3M Acquires Powell
      • 11.7.9 Gen-Probe Signs An Agreement With 3M Company
      • 11.7.10 3M Acquires Acolyte Biomedica
      • 11.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp
      • 11.7.12 3M Sells Its Pharmaceutical Business To Meda AB
      • 11.7.13 3M Acquires SoftMed Systems
      • 11.7.14 3M Sells its Pharmaceuticals Business to Graceway
      • 11.7.15 Gen-Probe Signs An Agreement With 3M
      • 11.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital
      • 11.7.17 3M Acquires Biotrace International
      • 11.7.18 Ekahau Secures $16 Million In Additional Funding
      • 11.7.19 3M Acquires Brontes Technologies
      • 11.7.20 3M acquires Nylonge Corp
      • 11.7.21 3M Signs An Agreement With ClozeX Medical
      • 11.7.22 3M Acquires OMNII Oral Pharmaceuticals
      • 11.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway
      • 11.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB
      • 11.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital
      • 11.7.26 3M Acquires Accuspray Application Technologies Inc
      • 11.7.27 3M to acquire Rochford Thompson Equipment
      • 11.7.28 3M To Acquire Aearo Technologies From Permira
      • 11.7.29 Permira To Sell Aearo Technologies To 3M
    • 11.8 Recent Developments
      • 11.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses
      • 11.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State
      • 11.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia
      • 11.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia
      • 11.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year
      • 11.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend
      • 11.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery
      • 11.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend
      • 11.8.9 May 08, 2007: 3M Declares Quarterly Dividend
      • 11.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
  • 12 Smith & Nephew Plc Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Advanced Wound Management
      • 12.2.2 Endoscopy
      • 12.2.3 Reconstruction
      • 12.2.4 Trauma and Clinical Therapies
      • 12.2.5 Products
      • 12.2.6 History
    • 12.3 Value Chain Analysis
      • 12.3.1 Manufacturing
      • 12.3.2 Product Development
      • 12.3.3 Sales and Marketing
    • 12.4 SWOT Analysis
      • 12.4.1 Smith & Nephew Plc Strengths
      • 12.4.2 Smith & Nephew Plc Weaknesses
      • 12.4.3 Smith & Nephew Plc Opportunities
      • 12.4.4 Smith & Nephew Plc Threats
    • 12.5 Financial and Operational Review
    • 12.6 Locations And Subsidiaries
    • 12.7 Financial Deals Landscape
      • 12.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein
      • 12.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services
      • 12.7.3 Smith & Nephew Acquires Plus Orthopedics Holding
      • 12.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement
      • 12.7.5 Smith & Nephew Acquires BlueSky Medical Group
      • 12.7.6 Smith & Nephew Enters Into An Agreement With Covalon
      • 12.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories
      • 12.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew
      • 12.7.9 Smith & Nephew Acquires Osteobiologics
      • 12.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement
      • 12.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity
      • 12.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew
      • 12.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies
      • 12.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft
      • 12.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
      • 12.7.16 Smith & Nephew Acquires VERSAJET From HydroCision
      • 12.7.17 Smith & Nephew Terminates Acquisition Of Biomet
    • 12.8 Recent Developments
      • 12.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend
      • 12.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results
      • 12.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America's Hip Generation
      • 12.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM
      • 12.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails
      • 12.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend
      • 12.8.7 May 03, 2007: Smith & Nephew Appoints New CEO
    • 12.9 Smith & Nephew Plc Pipeline Products
      • 12.9.1 R3 Modular resurfacing Acetabular system
      • 12.9.2 R3 Ceramic-on-ceramic Acetabular System
  • 13 Baxter International Company Profile
    • 13.1 Company Overview
    • 13.2 Business Overview
      • 13.2.1 BioScience
      • 13.2.2 Medication Delivery
      • 13.2.3 Renal
      • 13.2.4 Products
      • 13.2.5 History
    • 13.3 Value Chain Analysis
      • 13.3.1 Manufacturing
      • 13.3.2 Product Development
      • 13.3.3 Sales and Marketing
    • 13.4 SWOT Analysis
      • 13.4.1 Baxter International Inc. Strengths
      • 13.4.2 Baxter International Inc. Weaknesses
      • 13.4.3 Baxter International Inc. Opportunities
      • 13.4.4 Baxter International Inc. Threats
    • 13.5 Financial and Operational Review
    • 13.6 Locations And Subsidiaries
    • 13.7 Financial Deals Landscape
      • 13.7.1 Baiyunshan And Baxter Form A Joint Venture In China
      • 13.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
      • 13.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
      • 13.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
      • 13.7.5 Innovata signs a license agreement with Baxter International
      • 13.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
      • 13.7.7 Gambro Signs An Agreement With Baxter
      • 13.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
      • 13.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
      • 13.7.10 Baxter International And Kaketsuken Enter Into Agreement
      • 13.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
    • 13.8 Recent Developments
      • 13.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
      • 13.8.2 Dec 18, 2007: Baxter Elects CFO
      • 13.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
      • 13.8.4 Aug 01, 2007: Baxter Elects New Board Director
      • 13.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
      • 13.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
      • 13.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
      • 13.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
      • 13.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
    • 13.9 Baxter International Inc. Pipeline Products
      • 13.9.1 Next-Generation Home Hemodialysis Machine
  • 14 The HARTMANN GROUP Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Incontinence Management
      • 14.2.2 Operating Theater Management
      • 14.2.3 Other GROUP Activities
      • 14.2.4 Wound Management
      • 14.2.5 Products
      • 14.2.6 History
    • 14.3 Value Chain Analysis
      • 14.3.1 Manufacturing
      • 14.3.2 Product Development
      • 14.3.3 Sales and Marketing
    • 14.4 SWOT Analysis
      • 14.4.1 HARTMANN GROUP Strengths
      • 14.4.2 HARTMANN GROUP Weaknesses
      • 14.4.3 HARTMANN GROUP Opportunities
      • 14.4.4 HARTMANN GROUP Threats
    • 14.5 Financial and Operational Review
    • 14.6 Locations And Subsidiaries
    • 14.7 Recent Developments
      • 14.7.1 Mar 17, 2008: Hartmann Declares 2007 Results
      • 14.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia
      • 14.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm
      • 14.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results
  • 15 Regulation System
    • 15.1 Medical Equipment Approval Process
      • 15.1.1 Classification
      • 15.1.2 Registration and Conformity assessment
      • 15.1.3 China Compulsory Certificate (CCC Mark)
      • 15.1.4 Labeling and Packaging
      • 15.1.5 Registration Fee
      • 15.1.6 Registration Period
    • 15.2 Post Market Surveillance (PMS)
  • 16 Pricing and Reimbursement
  • 17 APPENDIX
    • 17.1 Global Markets Direct Research Methodology
    • 17.2 Coverage
    • 17.3 Secondary Research
    • 17.4 Primary Research
    • 17.5 Models
    • 17.6 Forecasts
    • 17.7 Expert Panels
    • 17.8 Currency Conversion
    • 17.9 Contact Us
    • 17.10 Disclaimer
  • List of Tables
    • Table 1: Doctors by Specialty in China, 2003-2007
    • Table 2: Hospital Wards by Specialty in China, 2003 - 2007
    • Table 3: Healthcare Institutions in China, 2000-2004
    • Table 4: Personnel Employed in Healthcare Institutions in China, 2000-2004
    • Table 5: Healthcare Institutions, Hospital Beds and Employed Personnel by Region in China, 2004
    • Table 6: Wound Care Management, China, Overall Revenues ($ mn), 2000-2012
    • Table 7: Wound Care Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 8: Wound Care Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 9: Wound Care Management, China, Category Revenues ($ mn), 2000-2012
    • Table 10: Wound Care Management, China, Category Revenues ($ mn), Historic, 2000-2007
    • Table 11: Wound Care Management, China, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 12: Wound Care Management, China, Category Volume (Units), 2000-2012
    • Table 13: Wound Care Management, China, Category Volume (Units), Historic, 2000-2007
    • Table 14: Wound Care Management, China, Category Volume (Units), Forecast, 2007-2012
    • Table 15: Wound Care Management, China, Overall Company Share by Revenue ($ mn), 2005-2006
    • Table 16: Wound Closure Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 17: Wound Closure Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 18: Wound Closure Devices, China, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 19: Wound Closure Devices, China, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 20: Skin Closure Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 21: Skin Closure Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Hemostats, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 23: Hemostats, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 24: Tissue Sealants, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 25: Tissue Sealants, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 26: Wound Closure Devices, China, Overall Volume (Units), Historic, 2000-2007
    • Table 27: Wound Closure Devices, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 28: Skin Closure Devices, China, Overall Volume (Units), Historic, 2000-2007
    • Table 29: Skin Closure Devices, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 30: Hemostats, China, Overall Volume (Units), Historic, 2000-2007
    • Table 31: Hemostats, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 32: Tissue Sealants, China, Overall Volume (Units), Historic, 2000-2007
    • Table 33: Tissue Sealants, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 34: Hemostats, China, Average Price ($), Historic, 2000-2007
    • Table 35: Hemostats, China, Average Price ($), Forecast, 2007-2012
    • Table 36: Tissue Sealants, China, Average Price ($), Historic, 2000-2007
    • Table 37: Tissue Sealants, China, Average Price ($), Forecast, 2007-2012
    • Table 38: Skin Closure Devices, China, Average Price ($), Historic, 2000-2007
    • Table 39: Skin Closure Devices, China, Average Price ($), Forecast, 2007-2012
    • Table 40: Wound Closure Devices, China, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 41: Wound Closure Devices, China, Company Share by Revenue ($ mn), 2005-2006
    • Table 42: Ostomy, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 43: Ostomy, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 44: Ostomy, China, Overall Volume (Units), Historic, 2000-2007
    • Table 45: Ostomy, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 46: Ostomy, China, Average Price ($), Historic, 2000-2007
    • Table 47: Ostomy, China, Average Price ($), Forecast, 2007-2012
    • Table 48: Ostomy, China, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 49: Ostomy, China, Company Share by Revenue ($ mn), 2005-2006
    • Table 50: Advanced Wound Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 51: Advanced Wound Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 52: Advanced Wound Management, China, Overall Volume (Units), Historic, 2000-2007
    • Table 53: Advanced Wound Management, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 54: Advanced Wound Management, China, Average Price ($), Historic, 2000-2007
    • Table 55: Advanced Wound Management, China, Average Price ($), Forecast, 2007-2012
    • Table 56: Advanced Wound Management, China, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 57: Advanced Wound Management, China, Company Share by Revenue ($ mn), 2005-2006
    • Table 58: Traditional Wound Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 59: Traditional Wound Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 60: Traditional Wound Management, China, Overall Volume (Units), Historic, 2000-2007
    • Table 61: Traditional Wound Management, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 62: Traditional Wound Management, China, Average Price ($), Historic, 2000-2007
    • Table 63: Traditional Wound Management, China, Average Price ($), Forecast, 2007-2012
    • Table 64: Traditional Wound Management, China, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 65: Traditional Wound Management, China, Company Share by Revenue ($ mn), 2005-2006
    • Table 66: Compression Therapy, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 67: Compression Therapy, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 68: Compression Therapy, China, Overall Volume (Units), Historic, 2000-2007
    • Table 69: Compression Therapy, China, Overall Volume (Units), Forecast, 2007-2012
    • Table 70: Compression Therapy, China, Average Price ($), Historic, 2000-2007
    • Table 71: Compression Therapy, China, Average Price ($), Forecast, 2007-2012
    • Table 72: Compression Therapy, China, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 73: Compression Therapy, China, Company Share by Revenue ($ mn), 2005-2006
    • Table 74: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007
    • Table 75: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
    • Table 76: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007
    • Table 77: Covidien Ltd./Tyco Healthcare, Other Locations
    • Table 78: Covidien Ltd./Tyco Healthcare, Subsidiaries
    • Table 79: 3M Company, SWOT Analysis, 2006
    • Table 80: 3M Company, Financial Statements, USD Million, 2002-2006
    • Table 81: 3M Company, Financial and Operational Overview, USD Million, 2002-2006
    • Table 82: 3M Company, Subsidiaries
    • Table 83: Smith & Nephew Plc, SWOT Analysis, 2006
    • Table 84: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
    • Table 85: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
    • Table 86: Smith & Nephew Plc, Other Locations
    • Table 87: Baxter International Inc., SWOT Analysis, 2006
    • Table 88: Baxter International Inc., Financial Statements, USD Million, 2002-2006
    • Table 89: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
    • Table 90: Baxter International Inc., Other Locations
    • Table 91: Baxter International Inc., Subsidiaries
    • Table 92: HARTMANN GROUP, SWOT Analysis, 2006
    • Table 93: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
    • Table 94: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
    • Table 95: HARTMANN GROUP, Subsidiaries
    • Table 96: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • List of Figures
    • Figure 1: Total Healthcare Expenditure in China, 2000 - 2005
    • Figure 2: Wound Care Management, China, Overall Revenues ($ mn), 2000-2012
    • Figure 3: Wound Care Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 4: Wound Care Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 5: Wound Care Management, China, Category Revenues ($ mn), 2000-2012
    • Figure 6: Wound Care Management, China, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 7: Wound Care Management, China, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 8: Wound Care Management, China, Category Volume (Units), 2000-2012
    • Figure 9: Wound Care Management, China, Category Volume (Units), Historic, 2000-2007
    • Figure 10: Wound Care Management, China, Category Volume (Units), Forecast, 2007-2012
    • Figure 11: Wound Care Management, China, Overall Company Share (%), 2006
    • Figure 12: Wound Closure Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 13: Wound Closure Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 14: Wound Closure Devices, China, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 15: Wound Closure Devices, China, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 16: Skin Closure Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 17: Skin Closure Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 18: Hemostats, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 19: Hemostats, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 20: Tissue Sealants, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 21: Tissue Sealants, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 22: Wound Closure Devices, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 23: Wound Closure Devices, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 24: Skin Closure Devices, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 25: Skin Closure Devices, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 26: Hemostats, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 27: Hemostats, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 28: Tissue Sealants, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 29: Tissue Sealants, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 30: Hemostats, China, Average Price ($), Historic, 2000-2007
    • Figure 31: Hemostats, China, Average Price ($), Forecast, 2007-2012
    • Figure 32: Tissue Sealants, China, Average Price ($), Historic, 2000-2007
    • Figure 33: Tissue Sealants, China, Average Price ($), Forecast, 2007-2012
    • Figure 34: Skin Closure Devices, China, Average Price ($), Historic, 2000-2007
    • Figure 35: Skin Closure Devices, China, Average Price ($), Forecast, 2007-2012
    • Figure 36: Wound Closure Devices, China, Distribution Share (%), 2006
    • Figure 37: Wound Closure Devices, China, Company Share (%), 2006
    • Figure 38: Ostomy, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 39: Ostomy, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 40: Ostomy, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 41: Ostomy, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 42: Ostomy, China, Average Price ($), Historic, 2000-2007
    • Figure 43: Ostomy, China, Average Price ($), Forecast, 2007-2012
    • Figure 44: Ostomy, China, Company Share (%), 2006
    • Figure 45: Advanced Wound Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 46: Advanced Wound Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 47: Advanced Wound Management, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 48: Advanced Wound Management, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 49: Advanced Wound Management, China, Average Price ($), Historic, 2000-2007
    • Figure 50: Advanced Wound Management, China, Average Price ($), Forecast, 2007-2012
    • Figure 51: Advanced Wound Management, China, Distribution Share (%), 2006
    • Figure 52: Advanced Wound Management, China, Company Share (%), 2006
    • Figure 53: Traditional Wound Management, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 54: Traditional Wound Management, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 55: Traditional Wound Management, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 56: Traditional Wound Management, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 57: Traditional Wound Management, China, Average Price ($), Historic, 2000-2007
    • Figure 58: Traditional Wound Management, China, Average Price ($), Forecast, 2007-2012
    • Figure 59: Traditional Wound Management, China, Distribution Share (%), 2006
    • Figure 60: Traditional Wound Management, China, Company Share (%), 2006
    • Figure 61: Compression Therapy, China, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 62: Compression Therapy, China, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 63: Compression Therapy, China, Overall Volume (Units), Historic, 2000-2007
    • Figure 64: Compression Therapy, China, Overall Volume (Units), Forecast, 2007-2012
    • Figure 65: Compression Therapy, China, Average Price ($), Historic, 2000-2007
    • Figure 66: Compression Therapy, China, Average Price ($), Forecast, 2007-2012
    • Figure 67: Compression Therapy, China, Distribution Share (%), 2006
    • Figure 68: Compression Therapy, China, Company Share (%), 2006
    • Figure 69: Covidien Ltd./Tyco Healthcare, Value Chain Analysis
    • Figure 70: 3M Company, Value Chain Analysis
    • Figure 71: Smith & Nephew Plc, Value Chain Analysis
    • Figure 72: Baxter International Inc., Value Chain Analysis
    • Figure 73: HARTMANN GROUP, Value Chain Analysis
    • Figure 74: Medical Equipment Registration Process in China, 2007
    • Figure 75: CCC Mark Certification Process in China, 2007
    • Figure 76: Global Markets Direct Methodology
+44 20 8816 8548

Ask a question about China Wound Care Management Industry Report

Enter the characters you see in the picture below
Captcha